FDA NDC Directory · JSON-LD · Markdown

dactinomycin

NDC 39822-2100 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerXGen Pharmaceuticals DJB, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA203999
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsDACTINOMYCIN (.5 mg/mL)
Marketing started20190731
Package count1

External sources

Source: openFDA. Public-domain (CC0).